Antibodies are passed to neonates by pregnant mothers who get the COVID-19 immunization.
Women who obtain their COVID-19 vaccine while pregnant can help protect their newborns against COVID-19.
According to a study published on Wednesday, pregnant women who received either the Pfizer-BioNTech or the Moderna vaccination transferred high levels of antibodies to their unborn children.
Researchers at the NYU Grossman School of Medicine discovered that once their mothers had received the vaccines, 100% of 36 infants examined at the time of birth had protective antibodies.
The highest levels of antibodies were found in the cord blood of moms who had been fully immunized in the second part of their pregnancy. This is linked to baby safety in the first few months of life.
Dr. Ashley Roman, director of maternal-fetal medicine at NYU Langone Health, said, “Studies continue to underscore the value of immunizations during pregnancy and their capacity to safeguard two lives at once by preventing serious sickness in both mothers and babies.”
“If newborns could be born with antibodies, it would protect them throughout their first few months of life, when they are most vulnerable,” Roman stated in a press release from the health system.
The researchers were also able to distinguish between antibodies produced in response to spontaneous infection and those produced in response to immunizations in newborn blood. This is significant because, according to the findings, normal antibody responses to the virus are insufficiently protective.
Despite the study’s limited sample size, study co-author Dr. Jennifer Lighter, a pediatric infectious disease expert at NYU Langone, stated, “it is encouraging that neonatal antibody levels are high if mothers get vaccinated.”
In a research published Aug. 16 in the American Journal of Obstetrics and Gynecology-Maternal Fetal Medicine, this team validated the solid evidence that the two mRNA vaccinations are safe during pregnancy.
There were no elevated risks, birth difficulties, or recognizable dangers to the fetus as a result of the immunization during pregnancy, according to the study.
According to data from the US Centers for Disease Control and Prevention, pregnant women are at a higher risk of serious disease from the virus, but just 23% of pregnant women have been vaccinated.
“Our findings add to a growing list of essential reasons why women should be encouraged to have the COVID-19 vaccine during pregnancy for the added benefit of providing critical protection to their newborn,” Lighter said in a statement.
Future research will be… Article Summary from Nokia News